Crossmark Global Holdings, Inc. Abiomed Inc Transaction History

Crossmark Global Holdings, Inc.

$5.61 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	SELL	$242.49 - $301.46 $36,373 - $45,219	-150 Reduced 5.51%	2,570 $631,000
Q1 2022 May 11, 2022	BUY	$277.25 - $366.29 $13,862 - $18,314	50 Added 1.87%	2,720 $901,000
Q4 2021 Jan 10, 2022	SELL	$300.63 - $371.35 $1.41 Million - $1.74 Million	-4,680 Reduced 63.67%	2,670 $959,000
Q3 2021 Oct 21, 2021	BUY	$310.19 - $376.2 $2.28 Million - $2.77 Million	7,350 New	7,350 $2.39 Million
Q3 2021 Oct 13, 2021	SELL	$310.19 - $376.2 $2.45 Million - $2.97 Million	-7,900 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$262.71 - $351.17 $136,609 - $182,608	-520 Reduced 6.18%	7,900 $2.47 Million
Q1 2021 Apr 15, 2021	SELL	$285.92 - $355.13 $325,948 - $404,848	-1,140 Reduced 11.92%	8,420 $2.68 Million
Q4 2020 Jan 14, 2021	BUY	$251.88 - $324.2 $1.68 Million - $2.16 Million	6,670 Added 230.8%	9,560 $3.1 Million
Q3 2020 Oct 08, 2020	SELL	$255.22 - $317.0 $33,178 - $41,210	-130 Reduced 4.3%	2,890 $801,000
Q2 2020 Aug 14, 2020	SELL	$141.4 - $257.09 $2,828 - $5,141	-20 Reduced 0.66%	3,020 $730,000
Q1 2020 Apr 28, 2020	SELL	$130.51 - $196.01 $13,573 - $20,385	-104 Reduced 3.31%	3,040 $441,000
Q4 2019 Feb 06, 2020	SELL	$159.31 - $223.54 $23,418 - $32,860	-147 Reduced 4.47%	3,144 $536,000
Q3 2019 Oct 09, 2019	BUY	$175.89 - $279.23 $8,618 - $13,682	49 Added 1.51%	3,291 $585,000
Q2 2019 Jul 09, 2019	BUY	$250.96 - $284.94 $26,099 - $29,633	104 Added 3.31%	3,242 $845,000
Q1 2019 May 02, 2019	SELL	$276.39 - $362.25 $30,126 - $39,485	-109 Reduced 3.36%	3,138 $896,000
Q4 2018 Jan 31, 2019	SELL	$281.08 - $444.25 $1.07 Million - $1.69 Million	-3,795 Reduced 53.89%	3,247 $1.06 Million
Q3 2018 Nov 08, 2018	BUY	$354.53 - $449.75 $32,616 - $41,377	92 Added 1.32%	7,042 $3.17 Million
Q2 2018 Jul 31, 2018	BUY	$278.07 - $446.21 $203,825 - $327,071	733 Added 11.79%	6,950 $2.84 Million
Q1 2018 Apr 16, 2018	SELL	$192.49 - $295.85 $59,671 - $91,713	-310 Reduced 4.75%	6,217 $1.81 Million
Q4 2017 Feb 05, 2018	SELL	$168.78 - $199.74 $95,023 - $112,453	-563 Reduced 7.94%	6,527 $1.22 Million
Q3 2016 Oct 25, 2017	BUY	N/A	7,090	7,090 $1.2 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account